NFL Biosciences Logo

NFL Biosciences

ISIN

FR0014003XT0

Ticker

ALNFL

Sector

Health Care

Sub-Industry

Biotechnology

Country

France

Year Founded

2006

About NFL Biosciences

Company Description

Making it possible to cure smoking addiction

NFL Biosciences develops a naturally based addiction withdrawal solution to help smokers willing to quit in their battle for a healthier life.

NFL Biosciences is a biotechnology company pioneering innovative solutions through a breakthrough approach based on a standardized extract of tobacco leaf. NFL-101 is NFL Biosciences current core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

Served Area

Worldwide

Headquarters

199 Rue Hélène Boucher
34170, Castelnau-le-Lez
France

Capital Markets Information

ISIN

FR0014003XT0

LEI

9695006VJWNTN4UNHA27

Sub-Industry

Biotechnology

Listed Stock Exchange

Euronext Paris

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.